BioPorto A/S
BIOPOR
Rangering i aksjer
#22814
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Aksjekurs
$0.16353606
Markedsverdi
$80.97M
Endring (1 dag)
-0.48%
Endring (1 år)
-43.22%
Land
DK
Handel BioPorto A/S (BIOPOR)
Kategori
Healthcare
Historikk for aksjesplitt for BioPorto A/S (BIOPOR)
Aksjen BioPorto A/S (symbol: BIOPOR) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én BIOPOR-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 BIOPOR-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én BIOPOR-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 BIOPOR-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
